Opus Point Partners Management’s GSK GSK Stock Holding History

Opus Point Partners Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-48,000	Closed	-$2.13M	–	56
2017 Q4	$2.13M	Hold	48,000	–	–	1.84%	17
2017 Q3	$2.44M	Hold	48,000	–	–	2.19%	14
2017 Q2	$2.59M	Hold	48,000	–	–	2.37%	12
2017 Q1	$2.53M	Hold	48,000	–	–	1.88%	25
2016 Q4	$2.31M	Hold	48,000	–	–	1.84%	26
2016 Q3	$2.59M	Buy	48,000 +8,000	+20%	+$439K	1.45%	27
2016 Q2	$2.17M	Buy	+40,000	New	+$2.11M	2.09%	23

Other funds holding GSK

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Opus Point Partners Management's GSK Position: Q1 2018 in Review

Opus Point Partners Management sold out of GSK (GSK) in Q1 2018, closing a stake of 48,000 shares — an estimated $2.13M sold.

Opus Point Partners Management first reported a position in GSK in Q2 2016 and held it in 7 quarters. The position peaked at $2.59M in Q3 2016. 779 funds tracked by Wall St. Rank hold GSK as of Q1 2018.

Opus Point Partners Management reported no remaining GSK position as of Q1 2018 after selling out during the quarter.
Opus Point Partners Management sold 48,000 GSK shares in Q1 2018, an estimated $2.13M.
Opus Point Partners Management first reported a position in GSK in Q2 2016 and held it in 7 quarters.
Opus Point Partners Management's GSK position peaked at $2.59M in Q3 2016.
779 funds tracked by Wall St. Rank held GSK as of Q1 2018.

Based on Opus Point Partners Management's 13F filing for Q1 2018, filed 15 May 2018.